Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05683041 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prevention of Intra-uterine Adhesions Following Laparoscopic and Laparotomic Myomectomy

Study acronym: PALLM
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 11 months later Jan 2027 → Jan 2029
See other at-risk trials from University Hospital, Ghent

Record History

  1. Primary completion pushed from Jan 2027 to Jan 2029
    • Study completion pushed from Jan 2028 to Jan 2030
    v5
  2. Primary completion date: Dec 2024 to Jan 2027
    • Study completion date: Dec 2024 to Jan 2028
    v4
  3. Re-verified, no change to tracked fieldsv3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jan 2023 to Feb 22, 2023
    • Site details revised
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Clinical study on the prevention of intrauterine adhesions after laparoscopic or laparotomic myomectomy. Myomas are common in women of reproductive age and myomectomy can lead to intra-uterine adhesions, which can be detrimental to fertility. This study investigates whether the use of an intrauterine gel can prevent the development of these adhesions.
Trial Details
NCT Number NCT05683041
Lead Sponsor University Hospital, Ghent
Collaborators: Nordic Pharma SAS
Conditions
(from sponsor)		 Myoma
Related terms Gynatresia, Myoma
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov